As the private sector contributes to advancing equity, corporate leaders are looking for ways to create positive impact through new practices, policies and, importantly—their core business. They consider how their purpose, culture, and governance align with their equity ambitions and the leadership it takes to bring commitments to fruition.
Hear from a Global Fortune 500 CEO who is reimagining the ways his company uses innovative science, technology, and an “inspired, curious, unbossed” culture to deliver greater access to medicines.
On November 29 at 10:30AM ET, Vas Narasimhan, M.D., CEO of global medicines company Novartis, talks with Alyson Shontell, Editor-in-Chief of Fortune, for a must-watch webinar that will cover topics of strategy, innovation, impact, and leadership, with learnings and advice relevant for all business leaders looking to advance equity today.
- Vas Narasimhan, M.D. – CEO, Novartis
- Alyson Shontell – Editor-in-Chief, Fortune
- Sebastien Mazzuri, M.D. (event host) – Managing Director, FSG
Interested in this session but unable to attend? All registrants will be sent a copy of the recording, within 1-2 business days of the live event.
November 29, 2022 | 10:30am ET | Check your time zone